Clinical Trials Arena on MSN1d
FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes
Last July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the ...
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.
Irish Star on MSN4mon
Two key superfoods lower blood sugar without needing insulin, experts say
Magnesium regulates an enzyme known as glucokinase, responsible for converting glucose into glucose-6-phosphate. Type 2 ...
vTv Therapeutics Inc.: vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall durati ...